Back HIV Policy & Advocacy

HIV Policy & Advocacy

CROI 2016: PopART Shows Feasibility of Reaching 90-90-90 HIV Testing and Treatment Targets

Early findings from the PopART study of the impact of a test-and-treat strategy on antiretroviral treatment coverage and HIV incidence show that after one round of household-based testing, linkage to care, and offer of immediate antiretroviral therapy, 90% of adults knew their HIV status and 71% of adults diagnosed with HIV were on treatment, according to preliminary findings presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston. The primary outcome of the study -- the impact of expanded treatment coverage on HIV incidence -- is expected to be reported in mid-2018.

alt

Read more:

CROI 2016: Botswana Close to Reaching 90-90-90 HIV Testing and Treatment Targets

Botswana is already close to reaching the 90-90-90 target for HIV testing, treatment, and viral suppression, and is ahead of the United States and most European countries in its efforts to improve treatment coverage, Tendani Gaolathe of the Botswana-Harvard AIDS Institute Partnership reported at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) this week in Boston.

alt

Read more:

4. Getting to Zero -- Progress Toward Ending HIV Epidemic

In July UNAIDS released a report showing that the Millennium Development Goal of getting 15 million people with HIV worldwide onto antiretroviral therapy (ART) by 2015 -- a goal many once considered impossible -- had been reached 9 months sooner than projected. Other targets have also been achieved or exceeded, as new HIV infections have decreased by 35% and AIDS-related deaths by 41%.

alt

Read more:

FY 2017 Budget Sustains HIV Funding, Requests More for PrEP, Opioid Epidemic

President Barack Obama's proposed budget for fiscal year 2017 modestly increases funding for domestic HIV services -- with $20 million allocated for a pre-exposure prophylaxis (PrEP) pilot programand $9 million for HIV/HCV coinfection -- but flat funds HIV research and global AIDS assistance. The budget also address the growing opioid epidemic and includes efforts to expand Medicaid and reduce prescription drug costs.

alt

Read more:

9. HIV and Hepatitis C Treatment Cost and Barriers to Access

Lack of access to HIV and hepatitis C treatment were key issues this year, as studies showed that type of health insurance affects the likelihood of successful treatment. HIV now has the potential to be a chronic manageable illness and hepatitis C can usually be cured, but major barriers and disparities continue to keep many people from accessing treatment.

alt

Read more: